Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Bristol Myers will enroll more patients in its Cobenfy Alzheimer's psychosis study after site irregularities, with FDA-supported analysis suggesting encouraging early signals.
Black Diamond posts strong Phase 2 lung cancer results with a 60% response rate and solid safety profile while preparing major trial updates and GBM expansion plans.
Signet signals a sturdier business heading into the holidays, but kept expectations cautious as value-focused shoppers and weak confidence weigh on demand.
Small-cap stocks powered higher Wednesday as expectations for a rate cut next week strengthened after weaker-than-expected private employment data. The Russell 2000 climbed more than 1% by midday in New York, lifted by rising odds of a 25-basis-point cut at the Fed's Dec. 10 meeting. The CME FedWatch tool shows a 90% chance of a move, with odds of another cut in January near 30%.
Five hours of diplomatic talks between Russian President Vladimir Putin and US envoys ended without progress on Tuesday, sending ripple effects through digital asset markets as geopolitical risk premiums resurface heading into year end.
Hims & Hers agrees to acquire YourBio Health, adding painless microneedle blood-sampling tech and expanding its at-home testing capabilities ahead of an early-2026 close.
Microsoft lowers AI software sales targets as clients hesitate to buy, highlighting tension between spending and usage. Nadella dismisses fully autonomous AI companies and emphasizes human agency. Stock falls despite strong performance and aggressive investments in AI and cloud infrastructure.
UK invites pharma executives to help design a new drug-pricing system following a fresh US–UK agreement that raises NHS costs but protects medicine exports.
A coalition of conservative advocacy groups — including former White House Chief Strategist Steve Bannon — has formally urged the Donald Trump administration to reject Big Tech's push to treat copyrighted materials as "free" fodder for training artificial-intelligence systems.
